16-85922065-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002163.4(IRF8):c.*783C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.397 in 152,172 control chromosomes in the GnomAD database, including 12,308 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 12292 hom., cov: 33)
Exomes 𝑓: 0.38 ( 16 hom. )
Consequence
IRF8
NM_002163.4 3_prime_UTR
NM_002163.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.408
Publications
36 publications found
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
IRF8 Gene-Disease associations (from GenCC):
- Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiencyInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Illumina
- immunodeficiency 32BInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.444 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IRF8 | NM_002163.4 | c.*783C>T | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000268638.10 | NP_002154.1 | ||
| IRF8 | NM_001363907.1 | c.*783C>T | 3_prime_UTR_variant | Exon 9 of 9 | NP_001350836.1 | |||
| IRF8 | NM_001363908.1 | c.*783C>T | 3_prime_UTR_variant | Exon 7 of 7 | NP_001350837.1 | |||
| IRF8 | XM_047434052.1 | c.*783C>T | 3_prime_UTR_variant | Exon 10 of 10 | XP_047290008.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.397 AC: 60291AN: 151896Hom.: 12261 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
60291
AN:
151896
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.380 AC: 60AN: 158Hom.: 16 Cov.: 0 AF XY: 0.386 AC XY: 34AN XY: 88 show subpopulations
GnomAD4 exome
AF:
AC:
60
AN:
158
Hom.:
Cov.:
0
AF XY:
AC XY:
34
AN XY:
88
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
55
AN:
136
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
3
AN:
14
Other (OTH)
AF:
AC:
2
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.397 AC: 60376AN: 152014Hom.: 12292 Cov.: 33 AF XY: 0.396 AC XY: 29384AN XY: 74284 show subpopulations
GnomAD4 genome
AF:
AC:
60376
AN:
152014
Hom.:
Cov.:
33
AF XY:
AC XY:
29384
AN XY:
74284
show subpopulations
African (AFR)
AF:
AC:
18646
AN:
41448
American (AMR)
AF:
AC:
4805
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
1194
AN:
3468
East Asian (EAS)
AF:
AC:
2019
AN:
5182
South Asian (SAS)
AF:
AC:
1185
AN:
4816
European-Finnish (FIN)
AF:
AC:
5065
AN:
10556
Middle Eastern (MID)
AF:
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26282
AN:
67972
Other (OTH)
AF:
AC:
829
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1872
3744
5616
7488
9360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1216
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.